Chemed CEO Retires, Successor Named
Ticker: CHE · Form: 8-K · Filed: Mar 13, 2024 · CIK: 19584
| Field | Detail |
|---|---|
| Company | Chemed Corp (CHE) |
| Form Type | 8-K |
| Filed Date | Mar 13, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $1, $85 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: leadership-change, executive-retirement
Related Tickers: CHE
TL;DR
Chemed CEO Tony Alvarez is retiring March 15th, David Watson takes over. Alvarez stays on as consultant.
AI Summary
On March 13, 2024, Chemed Corporation (NYSE: CHE) filed an 8-K to announce the retirement of its Chief Executive Officer, Tony G. Alvarez II, effective March 15, 2024. He will be succeeded by David L. Watson, who currently serves as President and Chief Operating Officer. Alvarez will remain with the company as a consultant until December 31, 2024.
Why It Matters
This filing marks a significant leadership transition for Chemed Corporation, potentially impacting its strategic direction and operational execution under new leadership.
Risk Assessment
Risk Level: medium — CEO transitions can introduce uncertainty regarding future strategy and performance, warranting a medium risk assessment.
Key Players & Entities
- Chemed Corporation (company) — Registrant
- Tony G. Alvarez II (person) — Retiring CEO
- March 15, 2024 (date) — Effective date of CEO retirement
- David L. Watson (person) — Incoming CEO
- December 31, 2024 (date) — End date of Alvarez's consultancy
FAQ
Who is the new CEO of Chemed Corporation?
David L. Watson will succeed Tony G. Alvarez II as CEO of Chemed Corporation.
When does the CEO transition take effect?
The retirement of Tony G. Alvarez II and the succession by David L. Watson are effective March 15, 2024.
Will the outgoing CEO remain involved with Chemed Corporation?
Yes, Tony G. Alvarez II will remain with the company as a consultant until December 31, 2024.
What is Chemed Corporation's ticker symbol?
Chemed Corporation's ticker symbol is CHE.
What is the filing date of this 8-K?
This 8-K filing was made on March 13, 2024.
Filing Stats: 534 words · 2 min read · ~2 pages · Grade level 13.4 · Accepted 2024-03-13 09:15:23
Key Financial Figures
- $1 — e on which registered Capital stock $1 par value CHE NYSE Indicate by ch
- $85 million — or profit corporation ("Covenant"), for $85 million. Covenant operates hospice services in
Filing Documents
- che-20240313x8k.htm (8-K) — 67KB
- che-20240313xex99_1.htm (EX-99.1) — 11KB
- che-20240313xex99_1g001.jpg (GRAPHIC) — 10KB
- 0001562762-24-000053.txt ( ) — 216KB
- che-20240313.xsd (EX-101.SCH) — 2KB
- che-20240313_lab.xml (EX-101.LAB) — 20KB
- che-20240313_pre.xml (EX-101.PRE) — 11KB
- che-20240313x8k_htm.xml (XML) — 5KB
01 Other Events
Item 8.01 Other Events. VITAS Acquisition On March 13, 2024, Chemed issued a press release announcing that VITAS Healthcare Corporation ("VITAS"), a wholly-owned indirect subsidiary of Chemed, entered into an Asset Purchase Agreement (the "Agreement") on March 12, 2024 to purchase substantially all of the hospice assets and an assisted living facility from Covenant Health and Community Services, inc. d/b/a Covenant Care, a Florida not for profit corporation ("Covenant"), for $85 million. Covenant operates hospice services in the panhandle of Florida and Alabama, including the Pensacola, Tallahassee, Marianna, Fort Walton Beach, Crestview and Panama City markets in Florida, and Dothan and Mobile market in Alabama. The purchase will be made using cash on-hand. The parties anticipate closing the transaction in the second quarter following receipt of certain regulatory and other approvals. A copy of the press release announcing the events described above is attached hereto as Exhibit 99.1. Page 2 of 4
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CHEMED CORPORATION Dated: March 13, 2024 By: /s/ Michael D. Witzeman Michael D. Witzeman Vice President and Controller Page 3 of 4 Exhibit Index Exhibit No. Description 99.1 Press Release dated March 13, 2024 104 The cover page from this Current Report on Form 8-K formatted in Incline XBRL Page 4 of 4